1. Home
  2. CASI vs MOBX Comparison

CASI vs MOBX Comparison

Compare CASI & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • MOBX
  • Stock Information
  • Founded
  • CASI 1991
  • MOBX 2020
  • Country
  • CASI China
  • MOBX United States
  • Employees
  • CASI N/A
  • MOBX N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • MOBX
  • Sector
  • CASI Health Care
  • MOBX
  • Exchange
  • CASI Nasdaq
  • MOBX Nasdaq
  • Market Cap
  • CASI 29.0M
  • MOBX 34.2M
  • IPO Year
  • CASI 1996
  • MOBX N/A
  • Fundamental
  • Price
  • CASI $1.33
  • MOBX $0.71
  • Analyst Decision
  • CASI Strong Buy
  • MOBX
  • Analyst Count
  • CASI 1
  • MOBX 0
  • Target Price
  • CASI $4.00
  • MOBX N/A
  • AVG Volume (30 Days)
  • CASI 287.9K
  • MOBX 238.3K
  • Earning Date
  • CASI 08-15-2025
  • MOBX 08-13-2025
  • Dividend Yield
  • CASI N/A
  • MOBX N/A
  • EPS Growth
  • CASI N/A
  • MOBX N/A
  • EPS
  • CASI N/A
  • MOBX N/A
  • Revenue
  • CASI $31,368,000.00
  • MOBX $10,692,000.00
  • Revenue This Year
  • CASI N/A
  • MOBX N/A
  • Revenue Next Year
  • CASI N/A
  • MOBX N/A
  • P/E Ratio
  • CASI N/A
  • MOBX N/A
  • Revenue Growth
  • CASI 8.39
  • MOBX 450.28
  • 52 Week Low
  • CASI $1.10
  • MOBX $0.55
  • 52 Week High
  • CASI $7.67
  • MOBX $2.47
  • Technical
  • Relative Strength Index (RSI)
  • CASI 28.60
  • MOBX 49.08
  • Support Level
  • CASI $1.10
  • MOBX $0.59
  • Resistance Level
  • CASI $2.07
  • MOBX $0.93
  • Average True Range (ATR)
  • CASI 0.28
  • MOBX 0.08
  • MACD
  • CASI -0.06
  • MOBX 0.01
  • Stochastic Oscillator
  • CASI 12.36
  • MOBX 38.03

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About MOBX Mobix Labs Inc.

Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.

Share on Social Networks: